Ocata Therapeutics, Inc.

CIK 1140098 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ocata Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 22, 201615-12B0001193125-16-471359
Feb 16, 2016SC 13G/A0001396835-16-000015
Feb 12, 2016SC 13G0001396835-16-000012
Feb 11, 2016EFFECT9999999995-16-003730
Feb 11, 201640001104659-16-095964
Feb 11, 201640001104659-16-095954
Feb 11, 2016SC 13D/A0000807249-16-000307
Feb 11, 2016EFFECT9999999995-16-003731
Feb 11, 201640001104659-16-095957
Feb 11, 201640001104659-16-095976
Feb 11, 201640001104659-16-095971
Feb 11, 2016EFFECT9999999995-16-003728
Feb 11, 201640001104659-16-095972
Feb 11, 2016EFFECT9999999995-16-003727
Feb 11, 2016EFFECT9999999995-16-003732
Feb 11, 2016EFFECT9999999995-16-003726
Feb 11, 201640001104659-16-095958
Feb 11, 201640001104659-16-095952
Feb 11, 201640001104659-16-095973
Feb 11, 201640001104659-16-095956
Feb 11, 201640001104659-16-095967
Feb 10, 2016POS AM0001193125-16-457653
Feb 10, 2016POS AM0001193125-16-457638
Feb 10, 2016POS AM0001193125-16-457637
Feb 10, 2016S-8 POS0001193125-16-457604